Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | CA3 | P07451 | 2/20 | 0.55 |
| ▸ | CA5A | P35218 | 2/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | OTC | P00480 | 1/20 | 0.47 |
| ▸ | ARG2 | P78540 | 4/20 | 0.44 |
| ▸ | ARG1 | P05089 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1604188 | 1.00 | ALDH1A1 (0.62) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL6033129 | 1.00 | ALDH1A1 (0.62) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL22679808 | 0.95 | ALDH1A1 (0.59) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL31296029 | 0.95 | ALDH1A1 (0.59) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL23728668 | 0.93 | ALDH1A1 (0.57) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL23728666 | 0.93 | ALDH1A1 (0.57) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL7322492 | 0.90 | ALDH1A1 (0.50) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL29361453 | 0.83 | GSR (0.46) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL26692311 | 0.83 | OTC (0.49) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL21689955 | 0.83 | GSR (0.48) | GSROTCARG2ARG1DDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042739-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | MANNKIND CORP (US) | 2026-02-12 | — | — | US | claimed |
| US-20250163003-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2025-05-22 | — | — | US | claimed |
| US-20240269301-A1 | METHOD FOR INITIATING POLYMERIZATION OF AMINO ACID N-CARBOXYANHYDRIDES IN AQUEOUS PHASE | PEKING UNIVERSITY (CN) | 2024-08-15 | — | — | US | claimed |
| US-12018057-B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | JANSSEN BIOTECH, INC. (US) | 2024-06-25 | — | — | US | claimed |
| CN-117776978-A | Preparation method of N epsilon- [ (9H-fluorene-9-ylmethoxy) carbonyl ] -L-lysine derivative | 长兴宜生药物科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20240092830-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | PEKING UNIVERSITY (CN) | 2024-03-21 | — | — | US | claimed |
| EP-4321179-A1 | METHOD FOR INITIATING POLYMERIZATION OF AMINO ACID N-CARBOXYANHYDRIDES IN AQUEOUS PHASE | Peking University (CN) | 2024-02-14 | — | — | EP | claimed |
| EP-4265600-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | Peking University (CN) | 2023-10-25 | — | — | EP | claimed |
| CN-116670120-A | Process for preparing carboxylic cyclic anhydride | 北京大学 | 2023-08-29 | — | — | CN | claimed |
| US-20220402983-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | JANSSEN BIOTECH, INC. | 2022-12-22 | — | — | US | claimed |
| EP-1807467-B1 | PROCESSES FOR PREPARING GLATIRAMER | SANDOZ AG (CH) | 2009-08-26 | — | — | EP | claimed |
| EP-2013628-A2 | METHODS OF EVALUATING PEPTIDE MIXTURES | Momenta Pharmaceuticals, Inc. (US) | 2009-01-14 | — | — | EP | claimed |
| US-20080021200-A1 | Processes for preparing a polypeptide | SANDOZ AG (CH) | 2008-01-24 | — | — | US | claimed |
| WO-2007127977-A2 | METHODS OF EVALUATING PEPTIDE MIXTURES | MOMENTA PHARMACEUTICALS, INC. (US) | 2007-11-08 | — | — | WO | claimed |
| CN-101044188-A | Process for preparing glatiramer | SANDOZ AG (CH) | 2007-09-26 | — | — | CN | claimed |
| EP-1807467-A1 | PROCESSES FOR PREPARING GLATIRAMER | Sandoz AG (CH) | 2007-07-18 | — | — | EP | claimed |
| US-20060154862-A1 | Processes for preparing a polypeptide | SANDOZ AG (CH) | 2006-07-13 | — | — | US | claimed |
| WO-2006050122-A1 | PROCESSES FOR PREPARING GLATIRAMER | SANDOZ AG (CH) | 2006-05-11 | — | — | WO | claimed |
| EP-0239062-B1 | N2-(1-CARBOXY-3-OXO-3-PHENYLPROPYL)-L-LYSINE COMPOUNDS AND THEIR DERIVATIVES | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-05-29 | — | — | EP | claimed |
| EP-0239062-A2 | N2-(1-carboxy-3-oxo-3-phenylpropyl)-L-Lysine compounds and their derivatives | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-09-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042739-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | ACMSD, DNPEP, PGM2 | ALDH1A1 4060/4885POLB 1629/4885SMN1; SMN2 4316/4885 |
| US-20250163003-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | PGM2, DNPEP, NPEPPS | ALDH1A1 4131/4885POLB 1165/4885SMN1; SMN2 4734/4885 |
| US-20220402983-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | IL23R, IL1RN, VIP | ALDH1A1 4574/4885POLB 4308/4885SMN1; SMN2 4301/4885 |
| US-20240092830-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | CA9, CA7, APEH | ALDH1A1 347/4885POLB 1218/4885SMN1; SMN2 4051/4885 |
| US-20240269301-A1 | METHOD FOR INITIATING POLYMERIZATION OF AMINO ACID N-CARBOXYANHYDRIDES IN AQUEOUS PHASE | DNPEP, DAO, BCAT1 | ALDH1A1 3280/4885POLB 345/4885SMN1; SMN2 2509/4885 |
| US-12018057-B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | IL23R, IL1RN, VIP | ALDH1A1 4574/4885POLB 4308/4885SMN1; SMN2 4301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.